Literature DB >> 19706026

Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation.

M Mennicke1, A Zawodniak, M Keller, L Wilkens, N Yawalkar, F Stickel, A Keogh, D Inderbitzin, D Candinas, W J Pichler.   

Abstract

DRESS syndrome (drug rash with eosinophilia and systemic symptoms) is a rare drug hypersensitivity reaction with a significant mortality. We describe a 60-year-old man with polyarthritis treated with sulfasalazine who developed DRESS and fulminant liver failure after additional vancomycin treatment. Liver histology revealed infiltration of granzymeB+ CD3+ lymphocytes in close proximity to apoptotic hepatocytes. After a superurgent liver transplantation and initial recovery, the patient developed recurrent generalized exanthema and eosinophilia, but only moderate hepatitis. Histology showed infiltration of FasL+ lymphocytes and eosinophils in the transplanted liver. Treatment with high-dose methylprednisolone was unsuccessful. Postmortem examination revealed extensive necrosis of the liver transplant. This case report illustrates that patients with DRESS may develop fulminant liver failure and that DRESS recurrence can recur in the transplanted liver. Histological and immunological investigations suggest an important role of granzymeB and FasL mediated cell death in DRESS associated hepatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706026     DOI: 10.1111/j.1600-6143.2009.02788.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

1.  Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.

Authors:  Thomas Wendland; Barbara Daubner; Werner J Pichler
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

Review 2.  Delayed drug hypersensitivity: models of T-cell stimulation.

Authors:  Jacqueline Adam; Werner J Pichler; Daniel Yerly
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 3.  Multiple Drug Hypersensitivity.

Authors:  Werner J Pichler; Yuttana Srinoulprasert; James Yun; Oliver Hausmann
Journal:  Int Arch Allergy Immunol       Date:  2017-03-18       Impact factor: 2.749

4.  [DRESS syndrome following sulfasalazine treatment].

Authors:  M Pirklbauer; J Gruber
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 5.  Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Authors:  S Shahzad Mustafa; David Ostrov; Daniel Yerly
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

Review 6.  Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Authors:  Richard J Weaver; Eric A Blomme; Amy E Chadwick; Ian M Copple; Helga H J Gerets; Christopher E Goldring; Andre Guillouzo; Philip G Hewitt; Magnus Ingelman-Sundberg; Klaus Gjervig Jensen; Satu Juhila; Ursula Klingmüller; Gilles Labbe; Michael J Liguori; Cerys A Lovatt; Paul Morgan; Dean J Naisbitt; Raymond H H Pieters; Jan Snoeys; Bob van de Water; Dominic P Williams; B Kevin Park
Journal:  Nat Rev Drug Discov       Date:  2019-11-20       Impact factor: 84.694

Review 7.  Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.

Authors:  M Mosedale; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2017-01-11       Impact factor: 6.875

8.  [DRESS syndrome. Rare and potentially lethal allergic reaction to carbamazepine - a case report].

Authors:  A Werber; M Schiltenwolf; A Barié
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

9.  Vancomycin-induced drug rash with eosinophilia and systemic symptoms (DRESS).

Authors:  Kyle Yuan; Kanwal S Awan; James Long
Journal:  BMJ Case Rep       Date:  2020-02-04

Review 10.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.